VFVA - Vanguard U.S. Value Factor ETF
| Assets | $316.32M |
| NAV | $94.85 |
| Expense Ratio | 0.14% |
| PE Ratio | 13.40 |
| Beta (5Y) | 1.46 |
| Dividend (ttm) | $1.56 |
| Dividend Yield | 1.65% |
| Ex-Dividend Date | Mar 22, 2021 |
| 1-Year Return | - |
| Trading Day | April 21 |
| Last Price | $96.30 |
| Previous Close | $94.91 |
| Change ($) | 1.39 |
| Change (%) | 1.46% |
| Day's Open | 94.65 |
| Day's Range | 94.65 - 96.39 |
| Day's Volume | 10,378 |
| 52-Week Range | 46.57 - 97.54 |
Fund Description
The investment seeks to provide long-term capital appreciation by investing in stocks with relatively lower share prices relative to fundamental values as determined by the advisor. The fund invests primarily in U.S. common stocks with the potential to generate higher returns relative to the broad U.S. equity market by investing in stocks with relatively lower share prices relative to fundamental values as determined by the advisor. Under normal circumstances, at least 80% of the fund's assets will be invested in securities issued by U.S. companies.
| Asset Class Equity | Inception Date Feb 13, 2018 |
| Exchange BATS | Ticker Symbol VFVA |
| Index Tracked CRSP U.S. Large Cap Value Index | |
Top 10 Holdings
6.82% of assets| Name | Symbol | Weight |
|---|---|---|
| Micron Technology | MU | 0.80% |
| HCA Healthcare | HCA | 0.74% |
| CVS Health | CVS | 0.71% |
| Kinder Morgan | KMI | 0.71% |
| Verizon | VZ | 0.69% |
| Exelon | EXC | 0.69% |
| Cigna | CI | 0.63% |
| Duke Energy | DUK | 0.63% |
| General Motors | GM | 0.62% |
| Morgan Stanley | MS | 0.61% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 22, 2021 | $0.3389 | Mar 25, 2021 |
| Dec 24, 2020 | $0.4828 | Dec 30, 2020 |
| Sep 21, 2020 | $0.3535 | Sep 24, 2020 |
| Jun 29, 2020 | $0.3879 | Jul 2, 2020 |
| Mar 23, 2020 | $0.3655 | Mar 26, 2020 |
| Dec 20, 2019 | $0.4985 | Dec 26, 2019 |
The momentum was driven by a vaccine development, which is being viewed as "a beginning to the end" of the coronavirus pandemic, and the prospect of divided congress, which is considered favorable for t...
While every corner of the market is enjoying the current ascent, high-beta ETFs and stocks seem a perfect bet at present.